KRISHI
ICAR RESEARCH DATA REPOSITORY FOR KNOWLEDGE MANAGEMENT
(An Institutional Publication and Data Inventory Repository)
"Not Available": Please do not remove the default option "Not Available" for the fields where metadata information is not available
"1001-01-01": Date not available or not applicable for filling metadata infromation
"1001-01-01": Date not available or not applicable for filling metadata infromation
Please use this identifier to cite or link to this item:
http://krishi.icar.gov.in/jspui/handle/123456789/68515
Title: | Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats |
Other Titles: | Not Available |
Authors: | Santhosh, S. Sini, T. K. Anandan, R. Mathew, P. T. |
ICAR Data Use Licennce: | http://krishi.icar.gov.in/PDF/ICAR_Data_Use_Licence.pdf |
Author's Affiliated institute: | ICAR::Central Institute of Fisheries Technology |
Published/ Complete Date: | 2006-02-15 |
Project Code: | Not Available |
Keywords: | Chitosan Isoniazid Rifampicin Hepatotoxicity Diagnostic marker enzymes Lipids Lipid peroxidation |
Publisher: | Elsevier |
Citation: | Santhosh, S., Sini, T. K., Anandan, R. and Mathew, P. T. (2006) Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats. Toxicology. 219(1-3) : 53-59. |
Series/Report no.: | Not Available; |
Abstract/Description: | We have studied the protective effect of chitosan on isoniazid- and rifampicin-induced hepatotoxicity with respect to the changes in the levels of diagnostic marker enzymes (in serum), lipid components and lipid peroxidation (in serum and liver). The oral administration of antitubercular drugs caused a significant elevation in the levels of diagnostic marker enzymes and cholesterol, triglycerides, free fatty acids and lipid peroxidation in serum and liver of experimental rats. There was a slight decline in the level of phospholipids in liver tissue also observed. Co-administration of chitosan significantly prevented the antitubercular drugs-induced elevation in the levels of serum diagnostic marker enzymes (alanine amino transferase, aspartate amino transferase, lactate dehydrogenase, acid phosphatase and alkaline phosphatase) in experimental groups of rats. It exerted a significant antilipidemic effect against isoniazid- and rifampicin-induced hepatitis by maintaining the levels cholesterol, triglycerides, free fatty acids and phospholipids in serum and liver at near normalcy. A tendency to prevent the isoniazid- and rifampicin-induced lipid peroxidation was also observed. The results of the present study indicated that the hepatoprotective effect of chitosan might be ascribable to its antilipidemic effect and/or antioxidant property. |
Description: | Not Available |
ISSN: | 0300-483X |
Type(s) of content: | Research Paper |
Sponsors: | Not Available |
Language: | English |
Name of Journal: | Toxicology |
Journal Type: | International Journal |
NAAS Rating: | 10.1 |
Impact Factor: | 4.10 |
Volume No.: | 219(1-3) |
Page Number: | 53-59 |
Name of the Division/Regional Station: | Not Available |
Source, DOI or any other URL: | https://doi.org/10.1016/j.tox.2005.11.001 |
URI: | http://krishi.icar.gov.in/jspui/handle/123456789/68515 |
Appears in Collections: | FS-CIFT-Publication |
Files in This Item:
There are no files associated with this item.
Items in KRISHI are protected by copyright, with all rights reserved, unless otherwise indicated.